Last updated: 3 October 2023 at 5:36pm EST

Bros. Advisors Lp667, L.P.B... Net Worth




The estimated Net Worth of Bros. Advisors Lp667, L.P.B... is at least $82.6 Milhão dollars as of 13 March 2023. Bros B owns over 40,000 units of Kodiak Sciences Inc stock worth over $82,604,027 and over the last 3 years Bros sold KOD stock worth over $0.

Bros B KOD stock SEC Form 4 insiders trading

Bros has made over 10 trades of the Kodiak Sciences Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Bros exercised 40,000 units of KOD stock worth $909,600 on 13 March 2023.

The largest trade Bros's ever made was buying 1,598,374 units of Kodiak Sciences Inc stock on 10 February 2022 worth over $106,947,204. On average, Bros trades about 246,783 units every 20 days since 2022. As of 13 March 2023 Bros still owns at least 33,442,926 units of Kodiak Sciences Inc stock.

You can see the complete history of Bros B stock trades at the bottom of the page.



Insiders trading at Kodiak Sciences Inc

Over the last 6 years, insiders at Kodiak Sciences Inc have traded over $15,919,920 worth of Kodiak Sciences Inc stock and bought 10,439,459 units worth $472,964,631 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Bros. Advisors Lp667, L.P.B..., eVictor Perlroth. On average, Kodiak Sciences Inc executives and independent directors trade stock every 27 days with the average trade being worth of $393,170. The most recent stock trade was executed by John A. Borgeson on 15 June 2024, trading 5,494 units of KOD stock currently worth $13,570.



What does Kodiak Sciences Inc do?

about kodiak kodiak is a high-science retinal medicines development company. we are aspiring to build a dominant global retina franchise. we are developing a top pipeline of proprietary best-in-class medicines for the treatment of patients with age-related macular degeneration and diabetic eye disease, two leading causes of blindness. our science begins with an antibody biopolymer product platform merging the fields of biologics and chemistry based therapies. in our medicines we aim to restore vision, to stop progression of underlying disease, and to require fewer treatments. working at kodiak we are passionate about preventing blindness and improving health. we take pride in scientific and operational excellence. the curiosity, creativity, and courage of our team members drives our progress. we highly value this culture and support it every way we can. kodiak supports a vibrant and active lifestyle. we have a top benefits package. we are within walking distance to california avenue sh



Complete history of Bros B stock trades at Incyte e Kodiak Sciences Inc

Acionista maioritário
Trans.
Transação
Preço total
Bros. Advisors Lp667, L.P.B...
Exercício de opção $909,600
13 Mar 2023
Bros. Advisors Lp667, L.P.B...
Comprar $28,107,139
8 Mar 2022
Bros. Advisors Lp667, L.P.B...
Comprar $35,733,640
17 Feb 2022
Bros. Advisors Lp667, L.P.B...
Comprar $106,947,204
10 Feb 2022
Bros. Advisors Lp667, L.P.B...
Comprar $4,447,152
2 Jun 2022
Bros. Advisors Lp667, L.P.B...
Comprar $2,365,241
25 May 2022
Bros. Advisors Lp667, L.P.B...
Comprar $2,699,038
16 May 2022
Bros. Advisors Lp667, L.P.B...
Comprar $21,832,544
15 Feb 2022
Bros. Advisors Lp667, L.P.B...
Comprar $18,085,533
27 Jan 2022
Bros. Advisors Lp667, L.P.B...
Comprar $28,808,871
21 Jan 2022


Kodiak Sciences Inc executives and stock owners

Kodiak Sciences Inc executives and other stock owners filed with the SEC include: